In HF with LVEF ≤ 42.5%, sacubitril-valsartan vs RAS inhibitors reduced a composite of CV death or HF hospitalization.

Journal Article

SOURCE CITATION: Solomon SD, Vaduganathan M, Claggett BL, et al. Sacubitril/valsartan across the spectrum of ejection fraction in heart failure. Circulation. 2020;141:352-61. 31736342.

Full Text

Duke Authors

Cited Authors

  • Sen, S; Newby, LK

Published Date

  • June 16, 2020

Published In

Volume / Issue

  • 172 / 12

Start / End Page

  • JC65 -

PubMed ID

  • 32539517

Pubmed Central ID

  • 32539517

Electronic International Standard Serial Number (EISSN)

  • 1539-3704

Digital Object Identifier (DOI)

  • 10.7326/ACPJ202006160-065

Language

  • eng

Conference Location

  • United States